Neuren Pharmaceuticals | NEU - Pre Tax Profit


Neuren Pharmaceuticals reported AUD19.21M in Pre-Tax Profit for its fiscal semester ending in December of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Clinuvel Pharmaceuticals AUD 28.8M 6.9M Jun/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Genetic Signatures AUD -2.45M 2.08M Jun/2025
Ionis Pharmaceuticals USD -114M 21M Jun/2026
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
Organon & Co USD 183M 30M Jun/2026
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Starpharma Holdings AUD -2.3M 1.94M Jun/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025
Viatris USD -247.3M 95.7M Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026